Andrzej Jakubowiak to North America
This is a "connection" page, showing publications Andrzej Jakubowiak has written about North America.
Connection Strength
0.042
-
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. Lancet. 2020 01 11; 395(10218):132-141.
Score: 0.042